HealthDay News — For patients with vasodilatory shock that does not respond to high-dose vasopressors, angiotensin II increases blood pressure, according to a study published online May 21 in the New ...

WASHINGTON -- Treatment with angiotensin II was associated with clinically relevant blood pressure increases in critically ill patients with vasodilatory shock who failed to respond to high doses of ...

Patients with vasodilatory shock, characterized by peripheral vasodilatation and low arterial blood pressure, who do not respond to vasopressors (catecholamines or vasopressin) have a poor prognosis.

Results showed that patients with a baseline APACHE II scores >30 had a significantly improved 28-day mortality trend in the angiotensin II group vs. the placebo group. The addition of angiotensin II ...

Angiotensin II drug to treat low blood pressure associated with septic shock has been approved by the United States Food and Drug Administration. U.S. Food and Drug Administration (USFDA) approves ...

Vasodilatory shock is a life-threatening syndrome that requires immediate treatment; conventional vasopressors have a narrow therapeutic window and toxicities at high doses. New research findings are ...